ALT FY 2012 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$329M

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$25M+3.7% YoY

Gross Profit

$25M100.0% margin

Operating Income

-$6M-24.9% margin

Net Income

-$5M-19.5% margin

EPS (Diluted)

$-30.55

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$23M

Total Liabilities

$11M

Stockholders' Equity

$12M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$24M	+3.7%
Gross Profit	$25M	$24M	+3.7%
Operating Income	-$6M	-$12M	+46.6%
Net Income	-$5M	-$4M	-29.6%